13,935 Shares in Avanos Medical, Inc. (NYSE:AVNS) Bought by Zacks Investment Management

Zacks Investment Management acquired a new position in shares of Avanos Medical, Inc. (NYSE:AVNS) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 13,935 shares of the company’s stock, valued at approximately $335,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. The Manufacturers Life Insurance Company grew its holdings in Avanos Medical by 3.6% during the second quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock worth $341,000 after acquiring an additional 590 shares during the period. KBC Group NV boosted its position in Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after purchasing an additional 1,095 shares in the last quarter. New York State Teachers Retirement System boosted its position in Avanos Medical by 2.0% during the third quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock worth $1,737,000 after purchasing an additional 1,388 shares in the last quarter. Quarry LP purchased a new stake in Avanos Medical during the third quarter worth $42,000. Finally, Foundry Partners LLC boosted its position in Avanos Medical by 1.1% during the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock worth $3,918,000 after purchasing an additional 1,800 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Stock Up 0.8 %

Shares of NYSE:AVNS opened at $18.69 on Wednesday. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 52-week low of $17.39 and a 52-week high of $25.36. The stock’s fifty day simple moving average is $20.56 and its 200-day simple moving average is $21.47. The company has a market capitalization of $858.99 million, a P/E ratio of 54.97 and a beta of 0.95.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.